Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Rhinitis Article
This is a selection made from among articles on Drug Treatment Rhinitis. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Drug and Alcohol Rehab
By Ken Marlborough
Rehabilitation from drug addiction is a complex process. It involves commitment from the individual addict to abstain from further drug use. The physical dependence on the drug needs to be overcome through medical intervention. Medical supervision is essential to safely detoxify an addicted individual. Safety is an issue since sudden withdrawal of a drug will lead to very profound physiological changes that can be very uncomfortable and can sometimes be life threatening. The range of drugs abused is wide but general principles apply to drug and alcohol rehabilitation.
After the medical detoxification process, which is often in an inpatient setting, a program to continue the rehab process as an outpatient is essential. Sometimes replacement drugs are needed such as methadone maintenance programs where patients are given methadone to replace the heroin that is abused. The methadone helps prevent the euphoria and at the same time decreases the craving that is central to addiction. A typical dose that may work is 30-60 milligrams of methadone daily but this is variable and depends on the intensity of addiction among other factors. Alcohol rehab often involves an acute hospital based detoxification where a thorough medical assessment is done and then drugs belonging to the class called benzodiazepines are given to prevent withdrawal. Medical issues are often the main reason an addict enters a treatment entry point.
After this acute phase an outpatient 12 step program such as Alcoholics Anonymous is critical to maintain abstinence. Many patients who are addicted to drugs have co-morbid psychiatric conditions like depression that need to be addressed. Others have HIV/AIDS, which also need to be managed if a lasting solution is needed. Many rehab programs are covered by insurance and charity. They also have social workers who will help with the practical aspects of getting back to a productive life.
Above all, the commitment of the individuals working in the program helps sustain and develop faith and trust in the system since addicts are often marginalized members of society.
Drug Rehab provides detailed information on Drug Rehab, Drug Rehab Programs, Drug Rehab Centers, Drug And Alcohol Rehab and more. Drug Rehab is affiliated with Drug Detox Rehab.
Article Source: http://EzineArticles.com/?expert=Ken_Marlborough
http://EzineArticles.com/?Drug-and-Alcohol-Rehab&id=231119
Drug Treatment Rhinitis Specific links
Drug Treatment Rhinitis News
MEDA: Dymista approved by the FDA
GÖTEBORG, Sweden--(BUSINESSWIRE)-- Regulatory News: The U.S. Food and Drug Administration (FDA) has approved Dymista, a new patented product for treatment of seasonal allergic rhinitis (SAR). In several ...
Read more...Press Release
The U.S. Food and Drug Administration (FDA) has approved Dymista, a new patented product for treatment of seasonal allergic rhinitis (SAR). In several clinical studies, Dymista has consistently showed a rapid and more complete symptom relief than standard treatment.
Read more...Sunovion Announces Upcoming Availability of ZETONNA™ (ciclesonide) Nasal Aerosol, a Non-Aqueous, Dry Nasal Aerosol ...
Sunovion Pharmaceuticals Inc. today announced the upcoming availability of ZETONNA™ Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis , also known as hay fever or nasal allergies.
Read more...Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews
NEW YORK, NY-- - Lost revenues as a result of expiring patents have been a growing problem for the big pharmaceutical companies. New products that are being introduced into the market place are not expected ...
Read more...Sun Pharma gets USFDA nod for nasal spray
Sun Pharmaceutical Industries today said it has received approval from the US health regulator to sell its generic version of Astelin, used in treating nasal allergies, in the American market.
Read more...Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red ...
LANCASTER, Pa. and ROCKVILLE, Md., May 3, 2012 /PRNewswire/ -- Immunomic Therapeutics, Inc., ("ITI," Lancaster, PA) a privately-held biotechnology company with laboratories in Rockville, MD, ...
Read more...Consort Gets FDA Approval For Its Integrated Dose Counter
Consort Gets FDA Approval For Its Integrated Dose Counter
Read more...Meda AB (Publ) – Interim Report, January-March 2012
Regulatory News:
Read more...MEDA Says FDA Approved Dymista - Quick Facts
MEDA Says FDA Approved Dymista - Quick Facts
Read more...Paladin Reports First Quarter 2012 Results Achieves Record Revenues
MONTREAL, CANADA-- - Paladin Labs Inc. , a leading specialty pharmaceutical company, today reported its financial results for the quarter ended March 31, 2012.2012 First Quarter HighlightsFinancial -- ...
Read more...